ZMIZ2 promotes the development of triple-receptor negative breast cancer

BACKGROUND: Triple-receptor negative breast cancer (TNBC) is an aggressive breast tumor subtype that generally has a poor prognosis. This study aimed to investigate the role and regulatory mechanisms of Zinc finger MIZ-type containing 2 (ZMIZ2) in relation to TNBC. METHODS: Based on data from The Ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Xiaopan, Liu, Yan, Di, Jun, Wei, Wei, Watanabe, Nobumoto, Li, Jiang, Li, Xiaomeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802436/
https://www.ncbi.nlm.nih.gov/pubmed/35101047
http://dx.doi.org/10.1186/s12935-021-02393-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802436/
https://www.ncbi.nlm.nih.gov/pubmed/35101047
http://dx.doi.org/10.1186/s12935-021-02393-x

Ejemplares similares